References
- Ruan R, et al. Global, Regional, and National Advances Toward the Management of Rheumatic Heart Disease Based on the Global Burden of Disease Study 2019. J Am Heart Assoc. 2023;12:
e028921 . DOI: 10.1161/JAHA.122.028921 - Li L, et al. Global, Regional, and National Burden of Nonrheumatic Valvular Heart Disease and Its Attributable Risk Factors in 204 Countries and Territories, 1990 to 2019: Results From the Global Burden of Disease Study 2019. J Am Heart Assoc. 2024;13:
e034459 . DOI: 10.1161/JAHA.124.034459 - Fleury MA, Clavel MA. Sex and Race Differences in the Pathophysiology, Diagnosis, Treatment, and Outcomes of Valvular Heart Diseases. Can J Cardiol. 2021;37:980–991. DOI: 10.1016/j.cjca.2021.02.003
- Liang X, Lyu Y, Li J, Li Y, Chi C. Global, regional, and national burden of preterm birth, 1990–2021: a systematic analysis from the global burden of disease study 2021. E Clinical Medicine. 2024;76:
102840 . DOI: 10.1016/j.eclinm.2024.102840 - GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2133–2161. DOI: 10.1016/S0140-6736(24)00757-8
- GBD 2021 Diseases and Injuries Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2100–2132. DOI: 10.1016/S0140-6736(24)00367-2
- Augustovski F, et al. Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions. Int J Health Policy Manag. 2018;7:120–136. DOI: 10.15171/ijhpm.2017.47
- Rosenberg PS, Check DP, Anderson WF. A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev. 2014;23:2296–2302. DOI: 10.1158/1055-9965.EPI-14-0300
- Xie Y, et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94:567–581. DOI: 10.1016/j.kint.2018.04.011
- Nitsche C, Koschutnik M, Kammerlander A, Hengstenberg C, Mascherbauer J. Gender-specific differences in valvular heart disease. Wien Klin Wochenschr. 2020;132:61–68. DOI: 10.1007/s00508-019-01603-x
- Onorati F, et al. Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry. J Thorac Cardiovasc Surg. 2014;147:1529–1539. DOI: 10.1016/j.jtcvs.2013.05.039
- Youssef G. Valvular heart diseases in women. Egypt Heart J. 2021;73:
58 . DOI: 10.1186/s43044-021-00184-3 - Malahfji M, Saeed M, Zoghbi WA. Aortic Regurgitation: Review of the Diagnostic Criteria and the Management Guidelines. Curr Cardiol Rep. 2023;25:1373–1380. DOI: 10.1007/s11886-023-01955-x
- Nkomo VT, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–1011. DOI: 10.1016/S0140-6736(06)69208-8
- Vassileva CM, et al. Gender differences in long-term survival of Medicare beneficiaries undergoing mitral valve operations. Ann Thorac Surg. 2013;96:1367–1373. DOI: 10.1016/j.athoracsur.2013.04.055
- Chang FC, et al. Sex Differences in Epidemiological Distribution and Outcomes of Surgical Mitral Valve Disease. Circ J. 2024;88:579–588. DOI: 10.1253/circj.CJ-23-0687
- Tran A, Ruel M, Chan V. Gender differences in outcomes following cardiac surgery: implications for managing patients with mitral valve disease. Curr Opin Cardiol. 2015;30:151–154. DOI: 10.1097/HCO.0000000000000150
- Coffey S, et al. Global epidemiology of valvular heart disease. Nat Rev Cardiol. 2021;18:853–864. DOI: 10.1038/s41569-021-00570-z
- Safiri S, et al. Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990–2019. Eur J Prev Cardiol. 2022;29:420–431. DOI: 10.1093/eurjpc/zwab213
- Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373:1382–1394. DOI: 10.1016/S0140-6736(09)60692-9
- Nejad M, et al. Global and regional burden and quality of care of non-rheumatic valvular heart diseases: a systematic analysis of Global Burden of Disease 1990–2017. Int J Qual Health Care. 2022;34. DOI: 10.1093/intqhc/mzac026
- Welt FGP, Fang JC. Pressure Volume System for Management of Heart Failure and Valvular Heart Disease. Curr Cardiol Rep. 2019;21:
153 . DOI: 10.1007/s11886-019-1247-0 - Crousillat DR, Wood MJ. Valvular Heart Disease and Heart Failure in Women. Heart Fail Clin. 2019;15:77–85. DOI: 10.1016/j.hfc.2018.08.008
- Vogel B, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet. 2021;397:2385–2438. DOI: 10.1016/S0140-6736(21)00684-X
